Citations

Showing 10 of 108152 citations.

A Contemporary Analysis of Urethral Recurrence following Radical Cystectomy
Khanna, Abhinav, Zganjar, Andrew , Lyon, Timothy D. , Shah, Paras , Tollefson, Matthew K. , Karnes, R. Jeffrey , Tarrell, Robert F., Thapa, Prabin , Thompson, R. Houston, Frank, Igor, Boorjian, Stephen A. , Lyon, Timothy, Tarrell, Robert, Lyon, Timothy D

Mayo Clinic

Journal of Urology | May 25, 2021 | Volume: 206 | Issue: 4 | Pages: 970-977

10.1097/ju.0000000000001842 | PMID 34032500 Get It

Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics
Wei, Yiping , Jasbi, Paniz , Shi, Xiaojian , Turner, C. H. , Hrovat, Jonathon, Liu, Li , Rabena, Yuri, Porter, Peggy L. , Gu, Haiwei , Turner, Cassidy

Mayo Clinic

Journal of Proteome Research | May 25, 2021 | Volume: 20 | Issue: 6 | Pages: 3124-3133

10.1021/acs.jproteome.1c00019 | PMID 34033488 Get It

Abstract Breast cancer (BC) is a common cause of morbidity and mortality, particularly in women. Moreover, the discovery of diagnostic biomarkers for early BC remains a challenging task. Previously, we [Jasbiet al.J. Chromatogr. B.2019, 1105, 26−37] demonstrated a targeted metabolic profiling approach capable of identifying metabolite marker candidates that could enable highly sensitive and specific detection of BC. However, the coverage of this targeted method was limited and exhibited suboptimal classification of early BC (EBC). To expand the metabolome coverage and articulate a better panel of metabolites or mass spectral features for classification of EBC, we evaluated untargeted liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS) data, both individually as well as in conjunction with previously published targeted LC-triple quadruple (QQQ)-MS data. Variable importance in projection scores were used to refine the biomarker panel, whereas orthogonal partial least squares-discriminant analysis was used to operationalize the enhanced biomarker panel for early diagnosis. In this approach, 33 altered metabolites/features were detected by LC-QTOF-MS from 124 BC patients and 86 healthy controls. For EBC diagnosis, significance testing and analysis of the area under receiver operating characteristic (AUROC) curve identified six metabolites/features [ethyl (R)-3-hydroxyhexanoate; caprylic acid; hypoxanthine; and m/z 358.0018, 354.0053, and 356.0037] with p < 0.05 and AUROC > 0.7. These metabolites informed the construction of EBC diagnostic models; evaluation of model performance for the prediction of EBC showed an AUROC = 0.938 (95% CI: 0.895–0.975), with sensitivity = 0.90 when specificity = 0.90. Using the combined untargeted and targeted data set, eight metabolic pathways of potential biological relevance were indicated to be significantly altered as a result of EBC. Metabolic pathway analysis showed fatty acid and aminoacyl-tRNA biosynthesis as well as inositol phosphate metabolism to be most impacted in response to the disease. The combination of untargeted and targeted metabolomics platforms has provided a highly predictive and accurate method for BC and EBC diagnosis from plasma samples. Furthermore, such a complementary approach yielded critical information regarding potential pathogenic mechanisms underlying EBC that, although critical to improved prognosis and enhanced survival, are understudied in the current literature. All mass spectrometry data and deidentified subject metadata analyzed in this study have been deposited to Mendeley Data and are publicly available (DOI: 10.17632/kcjg8ybk45.1).
Urticarial vasculitis revealing immunolabelled nucleocapsid protein of SARS‐CoV‐2 in two Brazilian asymptomatic patients: the tip of the COVID‐19 hidden iceberg?
Criado, Paulo Ricardo , Criado, Roberta Fachini Jardim , Gianotti, Raffaele , Abdalla, Beatrice Martinez Zugaib , Pincelli, Thaís , Michalany, Alexandre , Michalany, Nílceo Schwery , Criado, P R , Gianotti, R , Abdalla, Beatrice M Z , Pincelli, T

Mayo Clinic

Journal of the European Academy of Dermatology and Venereology | May 25, 2021 | Volume: 35 | Issue: 9 | Pages: No page available

10.1111/jdv.17391 | PMID 34033181 Get It

Navigating in Deep Waters: How Tissue Damage and Inflammation Shape Effector and Memory CD8+ T Cell Responses
Silva, Henrique Borges da , Borges da Silva, Henrique, Borges da Silva, Henrique

Mayo Clinic

ImmunoHorizons | May 25, 2021 | Volume: 5 | Issue: 5 | Pages: 338-348

10.4049/immunohorizons.2000102 | PMID 34035081 Get It

Abstract Memory CD8+ T cells promote protective immunity against viruses or cancer. Our field has done a terrific job identifying how CD8+ T cell memory forms in response to Ag. However, many studies focused on systems in which inflammation recedes over time. These situations, while relevant, do not cover all situations in which CD8+ T cell memory is relevant. It is increasingly clear that CD8+ T cells with a memory phenotype form in response to infections with extensive or prolonged tissue inflammation, for example, influenza, herpes, and more recently, COVID-19. In these circumstances, inflammatory mediators expectedly affect forming memory CD8+ T cells, especially in tissues in which pathogens establish. Notwithstanding recent important discoveries, many outstanding questions on how inflammation shapes CD8+ T cell memory remain unanswered. We will discuss, in this review, what is already known and the next steps to understand how inflammation influences CD8+ T cell memory.
Better Together: How Machine Learning Can Help Clinicians Determine If My Father Will Develop Parkinson Disease Dementia
Port, John D. , Port, John D

Mayo Clinic

Radiology | May 25, 2021 | Volume: 300 | Issue: 2 | Pages: 400-401

10.1148/radiol.2021210420 | PMID 34032517 Get It

Sex Differences, Genetic and Environmental Influences on Dilated Cardiomyopathy
Jain, Angita , Norton, Nadine , Bruno, Katelyn A. , Cooper, Leslie T. , Atwal, Paldeep S. , Fairweather, DeLisa , Atwal, Paldeep S , Fairweather, DeLisa , Cooper, Leslie T , Bruno, Katelyn A , Norton, Nadine

Mayo Clinic

Journal of Clinical Medicine | May 25, 2021 | Volume: 10 | Issue: 11 | Pages: 2289

10.3390/jcm10112289 | PMID 34070351 Get It

Dilated cardiomyopathy (DCM) is characterized by dilatation of the left ventricle and impaired systolic function and is the second most common cause of heart failure after coronary heart disease. The etiology of DCM is diverse including genetic pathogenic variants, infection, inflammation, autoimmune diseases, exposure to chemicals/toxins as well as endocrine and neuromuscular causes. DCM is inherited in 20–50% of cases where more than 30 genes have been implicated in the development of DCM with pathogenic variants in TTN (Titin) most frequently associated with disease. Even though male sex is a risk factor for heart failure, few studies have examined sex differences in the pathogenesis of DCM. We searched the literature for studies examining idiopathic or familial/genetic DCM that reported data by sex in order to determine the sex ratio of disease. We found 31 studies that reported data by sex for non-genetic DCM with an average overall sex ratio of 2.5:1 male to female and 7 studies for familial/genetic DCM with an overall average sex ratio of 1.7:1 male to female. No manuscripts that we found had more females than males in their studies. We describe basic and clinical research findings that may explain the increase in DCM in males over females based on sex differences in basic physiology and the immune and fibrotic response to damage caused by mutations, infections, chemotherapy agents and autoimmune responses.
Recommendations for Statistical Reporting in Cardiovascular Medicine: A Special Report From the American Heart Association
Althouse, Andrew D. , Below, Jennifer E , Claggett, Brian , Cox, Nancy J. , Lemos, James A. de , Deo, Rahul C. , Duval, Sue , Hachamovitch, Rory , Kaul, Sanjay , Keith, Scott W. , Teixeira‐Pinto, Armando , Roger, Véronique L. , Below, Jennifer E , Secemsky, Eric A.

Mayo Clinic

Circulation | May 25, 2021 | Volume: 144 | Issue: 4 | Pages: No page available

10.1161/circulationaha.121.055393 | PMID 34032474 Get It

Statistical analyses are a crucial component of the biomedical research process and are necessary to draw inferences from biomedical research data. The application of sound statistical methodology is a prerequisite for publication in the American Heart Association (AHA) journal portfolio. The objective of this document is to summarize key aspects of statistical reporting that might be most relevant to the authors, reviewers, and readership of AHA journals. The AHA Scientific Publication Committee convened a task force to inventory existing statistical standards for publication in biomedical journals and to identify approaches suitable for the AHA journal portfolio. The experts on the task force were selected by the AHA Scientific Publication Committee, who identified 12 key topics that serve as the section headers for this document. For each topic, the members of the writing group identified relevant references and evaluated them as a resource to make the standards summarized herein. Each section was independently reviewed by an expert reviewer who was not part of the task force. Expert reviewers were also permitted to comment on other sections if they chose. Differences of opinion were adjudicated by consensus. The standards presented in this report are intended to serve as a guide for high-quality reporting of statistical analyses methods and results.
Aerosol Generation During Peak Flow Testing: Clinical Implications for COVID-19
Subat, Yosuf W., Guntupalli, Siva Kamal, Sajgalik, Pavol , Hainy, Matthew E, Torgerud, Keith D, Johnson, Bruce D. , Allison, Thomas G. , Helgeson, Scott A. , Lim, Kaiser G. , Niven, Alexander S.

Mayo Clinic

Respiratory Care | May 25, 2021 | Volume: 66 | Issue: 8 | Pages: 1291-1298

10.4187/respcare.08731 | PMID 34035146 Get It

BACKGROUND: Peak flow testing is a common procedure performed in ambulatory care. There are currently no data regarding aerosol generation during this procedure. Given the ongoing debate regarding the potential for aerosol transmission of SARS-CoV-2, we aimed to quantify and characterize aerosol generation during peak flow testing. METHODS: Five healthy volunteers performed peak flow maneuvers in a particle-free laboratory space. Two devices continuously sampled the ambient air during the procedure. One device can detect ultrafine particles 0.02–1 μ m in diameter, while the second device can detect particles 0.3, 0.5, 1.0, 2.0, 5.0, and 10 μ m in diameter. Five different peak flow meters were compared to ambient baseline during masked and unmasked tidal breathing. RESULTS: Ultrafine particles (0.02–1 μ m) were generated during peak flow measurement. There was no significant difference in ultrafine particle mean concentration between peak flow meters ( P = .23): Respironics (1.25 ± 0.47 particles/mL), Philips (3.06 ± 1.22), Clement Clarke (3.55 ± 1.22 particles/mL), Respironics Low Range (3.50 ± 1.52 particles/mL), and Monaghan (3.78 ± 1.31 particles/mL). Ultrafine particle mean concentration with peak flow testing was significantly higher than masked (0.22 ± 0.29 particles/mL) and unmasked tidal breathing (0.15 ± 0.18 particles/mL, P = .01), but the ultrafine particle concentrations were small compared to ambient particle concentrations in a pulmonary function testing room (89.9 ± 8.95 particles/mL). CONCLUSIONS: In this study, aerosol generation was present during peak flow testing, but concentrations were small compared to the background particle concentration in the ambient clinical environment. Surgical masks and eye protection are likely sufficient infection control measures during peak expiratory flow testing in asymptomatic patients with well controlled respiratory symptoms, but COVID-19 testing remains prudent in patients with acute respiratory symptoms prior to evaluation and peak expiratory flow assessment while the community prevalence of SARS-CoV-2 cases remains high.
In Response
Guinn, Nicole R. , Warner, Matthew A.

Mayo Clinic

Anesthesia & Analgesia | May 25, 2021 | Volume: 132 | Issue: 6 | Pages: e109-e110

10.1213/ane.0000000000005493 | PMID 34032674 Get It

The Time to Seriously Reassess the Use and Misuse of Neuromuscular Blockade in Children Is Now
Tobias, Joseph D. , Brull, Sorin J. , Brull, Sorin J , Renew, J. Ross

Mayo Clinic

Anesthesia & Analgesia | May 25, 2021 | Volume: 132 | Issue: 6 | Pages: 1514-1517

10.1213/ane.0000000000005488 | PMID 34032656 Get It